Regulation of NKG2D Ligand Gene Expression

Human Immunology

Volumn 67, Issue 3, 2006, Pages 159-169

  Eagle, Robert A ^a   Traherne, James A ^a   Ashiru, Omodele ^b   Wills, Mark R ^b   Trowsdale, John ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HCMV; ligand; NK cell; NKG2D; polymorphism; promoter

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN; RETINOIC ACID; RETINOIC ACID EARLY TRANSCRIPT PROTEIN; UL16 BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; UPREGULATION; VIRUS STRAIN;

ALLELES; BASE SEQUENCE; CELL LINE; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 33646341760     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.015     Document Type: Article

References (49)

1. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 (2003) 781
2. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., and Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285 (1999) 730
3. Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M., and Cosman D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 168 (2002) 671
4. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., and Spies T. Costimulation of CD8aa T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2 (2001) 255
5. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., and Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17 (2002) 19
6. + T cells. J Immunol 174 (2005) 1922
7. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., and Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727
8. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., and Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123
9. Chalupny N.J., Sutherland C.L., Lawrence W.A., Rein-Weston A., and Cosman D. ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305 (2003) 129
10. Bacon L., Eagle R.A., Meyer M., Easom N., Young N.T., and Trowsdale J. Two Human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 173 (2004) 1073
11. Radosavljevic M., Cuillerier B., Wilson M.J., Clement O., Wicker S., Gilfillan S., Beck S., Trowsdale J., and Bahram S. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 79 (2002) 1
12. Zhou Z., Nomura M., Takihara Y., Yasunaga T., and Shimada K. Isolation and characterisation of retinoic acid-inducible cDNA clones in F9 cells. a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J Biochem 119 (1996) 319
13. Malarkannan S, Shih PP, Eden PA, Horng T, Zuberi AR, Christianson G, Roopenian D, Shastri N: The molecular and functional characterisation of a dominant minor Hantigen, H60. J Immunol 161:3501.
14. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., and Raulet D.H. Ligands for the murine NKG2D receptor. expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1 (2000) 119
15. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., and Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 (2000) 721
16. Carayannopoulos L.N., Naidenko O.V., Fremont D.H., and Yokoyama W.M. Cutting edge: Murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 169 (2002) 4079
17. Gleimer M., and Parham P. Stress management. MHC class I and class I-like molecules as reporters of cellular stress. Immunity 19 (2003) 469
18. Hamerman J.A., Ogasawara K., and Lanier L.L. NK cells in innate immunity. Curr Opin Immunol 17 (2005) 29
19. Welte S.A., Sinzger C., Lutz S.Z., Singh-Jasuja H., Sampaio K.L., Eknigk U., Rammensee H.G., and Steinle A. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33 (2003) 194
20. Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V., Johnson D.C., and Cosman D. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197 (2003) 1427
21. Rolle A., Mousavi-Jazi M., Eriksson M., Odeberg J., Soderberg-Naucler C., Cosman D., Karre K., and Cerboni C. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells. up-regulation of UL16-binding protein (ULBP)1 and ULBP2 counteracted by the viral UL16 protein. J Immunol 171 (2003) 902
22. Wu J., Chalupny N.J., Manley T.J., Riddell S.R., Cosman D., and Spies T. Intracellular retention of the MHC class I-related B ligands of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol 170 (2003) 4196
23. Eleme K., Taner S.B., Önfelt B., Collinson L.M., McCann F.E., Chalupny N.J., Cosman D., Hopkins C., Magee A.I., and Davis D.M. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J Exp Med 199 (2004) 1005
24. Suemizu H., Radosavljevic M., Kimura M., Sadahiro S., Yoshimura S., Bahram S., and Inoko H. A basolateral sorting motif in the MICA cytoplasmic tail. Proc Natl Acad Sci USA 99 (2002) 2971
25. O'Callaghan C.A., Cerwenka A., Willcox B.E., Lanier L.L., and Bjorkman P.J. Molecular competition for NKG2D. H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity 15 (2001) 201
26. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., and Spies T. Cell stress- regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93 (1996) 12445
27. Molinero L.L., Fuertes M.B., Girat M.V., Fainboim L., Rabinovich G.A., Costas M.A., and Zwirner N.W. NF-kappa B regulates expression of the MHC class I related chain A gene in activated T lymphocytes. J Immunol 173 (2004) 5583
28. Jinushi M., Takehara T., Kanto T., Tatsumi T., Groh V., Spies T., Miyagi T., Suzuki T., Sasaki Y., and Hayashi N. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation. impairment in chronic hepatitis C infection. J Immunol 170 (2003) 1249
29. Hamerman J.A., Ogasawara K., and Lanier L.L. Cutting Edge. Toll-like receptor signalling in macrophages induces ligands for the NKG2D receptor. J Immunol 172 (2004) 2001
30. Allcock R.J.N., Barrow A.D., Forbes S., Beck S., and Trowsdale J. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 33 (2003) 567
31. Trinklin N.D., Aldred S.J., Saldanha A.J., and Meyers R.M. Identification and functional analysis of human transcriptional promoters. Genome Res 13 (2003) 308
32. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., and Werner T. MatInspector and beyond. promoter analysis based on transcription factor binding sites. Bioinformatics 21 (2005) 2933
33. Kumar S., Tamura K., and Nei M. MEGA3. Integrated Software for Molecular Evolutionary Genetics Analysis and Sequence Alignment. Briefings in Bioinformatics 5 (2004) 150
34. Allcock R.J., Atrazhev A.M., Beck S., de Jong P.J., Elliott J.F., Forbes S., Halls K., Horton R., Osoegawa K., Rogers J., Sawcer S., Todd J.A., Trowsdale J., Wang Y., and Williams S. The MHC haplotype project. a resource for HLA-linked association studies. Tissue Antigens 59 (2002) 520
35. Cha T.A., Tom E., Kemble G.W., Duke G.W., Mocarski E.S., and Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70 (1996) 476
36. Hromas R., Collins S.J., Hickstein D., Raskind W., Deaven L.L., O'Hara P., Hagen F.S., and Kaushansky K. A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem 266 (1991) 14183
37. Tseng H., and Green H. Basonuclin. a keratinocyte protein with multiple paired zinc fingers. Proc Nat Acad Sci USA 89 (1992) 10311
38. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature (2005) epub ahead of print
39. Yoshida H., Matsui T., Yamamoto A., Okada T., and Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107 (2001) 881
40. Groh V., Steinle A., Bauer S., and Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279 (1998) 1737
41. Au W.-C., Yeouw W.-S., and Pitha P.M. Analysis of functional domain of interferon regulatory factor 7 and its association with IRF-3. Virology 280 (2001) 273
42. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772
43. Pende D., Rivera P., Marcenaro S., Chang C.C., Biassoni R., Conte R., Kubin M., Cosman D., Ferrone S., Moretta L., and Moretta A. Major histocompatability complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histiotypes. analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62 (2002) 6178
44. Stephens H.A. MHC haplotypes, MICA genes and the 'wonderland' of NK receptor polymorphism. Trends Immunol 23 (2002) 385
45. Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K., and Spies T. Interactions of human NKG2D with its ligands MICA, MICB and homologs of the mouse RAE-I protein family. Immunogenetics 53 (2001) 279
46. Cowles C.R., Hirschhom J.N., Altschuler D., and Lander E.S. Detection of regulatory variation in mouse genes. Nat Genet 32 (2002) 432
47. Esterbauer H., Schneitler C., Oberkofler H., Ebenbichler C., Paulweber B., Sandhofer F., Ladurner G., Hell E., Strosberg A.D., Patsch J.R., Krempler F., and Patsch W. A common polymorphism in the promoter of UCP2 is aossciated with decreased risk of obesity in middle-aged humans. Nat Genet 28 (2001) 178
48. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski A., Kalayanarooj S.M., Tangnararatchakit K., Tangthawomchaikul N., Vasanawathana S., Chaiyaratana W., Yenchitsomanus P.T., Suriyaphol P., Avirutnan P., Chokephaibulkit K., Matsuda F., Yoksan S., Jacob Y., Lathrop G.M., Malasit P., Despres P., and Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37 (2005) 507
49. Swanberg M., Lidman O., Padyukov L., Eriksson P., Akesson E., Jagodic M., Lobell A., Khademi M., Borjesson O., Lindgren C.M., Lundman P., Brookes A.J., Kere J., Luthman H., Alfredsson L., Hillert J., Klareskog L., Hamsten A., Piehl F., and Olsson T. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37 (2005) 486